These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23222714)

  • 41. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.
    Chin AI; Miyahira AK; Covarrubias A; Teague J; Guo B; Dempsey PW; Cheng G
    Cancer Res; 2010 Apr; 70(7):2595-603. PubMed ID: 20233880
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD4
    Liu S; Liu F; Zhang B; Yan P; Rowan BG; Abdel-Mageed AB; Steele C; Jazwinski SM; Moroz K; Norton EB; Wang A; Myers L; Sartor O; Zhang Q
    Prostate; 2020 Jul; 80(10):764-776. PubMed ID: 32356608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. OGR1 mediates the inhibitory effects of acidic environment on proliferation and angiogenesis of endothelial progenitor cells.
    Ding S; Xu J; Zhang Q; Chen F; Zhang J; Gui K; Xiong M; Li B; Ruan Z; Zhao M
    Cell Biol Int; 2019 Nov; 43(11):1307-1316. PubMed ID: 31115941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice.
    Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L
    Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice.
    Grizzle WE; Xu X; Zhang S; Stockard CR; Liu C; Yu S; Wang J; Mountz JD; Zhang HG
    Mech Ageing Dev; 2007; 128(11-12):672-80. PubMed ID: 18036633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.
    Chae M; Peterson TE; Balgeman A; Chen S; Zhang L; Renner DN; Johnson AJ; Parney IF
    Neuro Oncol; 2015 Jul; 17(7):978-91. PubMed ID: 25537019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
    Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased bone density in mice lacking the proton receptor OGR1.
    Krieger NS; Yao Z; Kyker-Snowman K; Kim MH; Boyce BF; Bushinsky DA
    Kidney Int; 2016 Mar; 89(3):565-73. PubMed ID: 26880453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer.
    Riabov V; Kim D; Chhina S; Alexander RB; Klyushnenkova EN
    Cancer Immunol Immunother; 2015 Jul; 64(7):873-83. PubMed ID: 25893810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b
    Takahashi R; Amano H; Ito Y; Eshima K; Satoh T; Iwamura M; Nakamura M; Kitasato H; Uematsu S; Raouf J; Jakobsson PJ; Akira S; Majima M
    Biomed Pharmacother; 2020 Jan; 121():109581. PubMed ID: 31715374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer.
    Feng PH; Lee KY; Chang YL; Chan YF; Kuo LW; Lin TY; Chung FT; Kuo CS; Yu CT; Lin SM; Wang CH; Chou CL; Huang CD; Kuo HP
    Am J Respir Crit Care Med; 2012 Nov; 186(10):1025-36. PubMed ID: 22955317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
    Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
    Front Immunol; 2019; 10():1273. PubMed ID: 31214202
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The proton-activated G protein coupled receptor OGR1 acutely regulates the activity of epithelial proton transport proteins.
    Mohebbi N; Benabbas C; Vidal S; Daryadel A; Bourgeois S; Velic A; Ludwig MG; Seuwen K; Wagner CA
    Cell Physiol Biochem; 2012; 29(3-4):313-24. PubMed ID: 22508039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breaking immune tolerance by targeting CD25+ regulatory T cells is essential for the anti-tumor effect of the CTLA-4 blockade in an HLA-DR transgenic mouse model of prostate cancer.
    Klyushnenkova EN; Riabov VB; Kouiavskaia DV; Wietsma A; Zhan M; Alexander RB
    Prostate; 2014 Oct; 74(14):1423-32. PubMed ID: 25111463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype.
    Munder M; Eichmann K; Modolell M
    J Immunol; 1998 Jun; 160(11):5347-54. PubMed ID: 9605134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK.
    Yang Y; Zhang R; Xia F; Zou T; Huang A; Xiong S; Zhang J
    Exp Cell Res; 2013 Jul; 319(12):1774-1783. PubMed ID: 23701951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutting edge: permissive MHC class II allele changes the pattern of antitumor immune response resulting in failure of tumor rejection.
    Klyushnenkova EN; Kouiavskaia DV; Berard CA; Alexander RB
    J Immunol; 2009 Feb; 182(3):1242-6. PubMed ID: 19155468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
    Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycle.
    Zhang Q; Yang XJ; Kundu SD; Pins M; Javonovic B; Meyer R; Kim SJ; Greenberg NM; Kuzel T; Meagher R; Guo Y; Lee C
    Mol Cancer Ther; 2006 Jul; 5(7):1733-43. PubMed ID: 16891459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
    Lu R; Kujawski M; Pan H; Shively JE
    Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.